Celyad SA (CYAD)

Currency in EUR
0.23
-0.02(-8.80%)
Real-time Data·
CYAD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.230.23
52 wk Range
0.160.65
Key Statistics
Prev. Close
0.25
Open
0.23
Day's Range
0.23-0.23
52 wk Range
0.16-0.65
Volume
26.74K
Average Volume (3m)
15.47K
1-Year Change
-34.8571%
Book Value / Share
0.05
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CYAD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Celyad SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 29, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CYAD Income Statement

Compare CYAD to Peers and Sector

Metrics to compare
CYAD
Peers
Sector
Relationship
P/E Ratio
12.4x−0.3x−0.4x
PEG Ratio
0.12−0.080.00
Price/Book
4.2x1.1x2.6x
Price / LTM Sales
490.2x0.9x3.0x
Upside (Analyst Target)
-228.8%56.2%
Fair Value Upside
Unlock15.6%8.9%Unlock

Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
45.37K0.10%11.34K
Other Institutional Investors
30.40M67.92%7.60M
Public Companies & Retail Investors
14.32M31.98%3.58M
Total
44.76M100.00%11.19M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Fortress Investment Group LLC58.51%26,191,9876,548
Tolefi S.A.9.40%4,209,1631,052

People Also Watch

175.80
DEME
-0.90%
8.09
XFAB
-2.82%
285.80
ACKB
-0.42%
26.62
SOLB
-1.33%
32.52
ARDS
-1.57%

FAQ

What Is the Celyad (CYAD) Stock Price Today?

The Celyad stock price today is 0.23 EUR.

What Stock Exchange Does Celyad Trade On?

Celyad is listed and trades on the Brussels Stock Exchange.

What Is the Stock Symbol for Celyad?

The stock symbol for Celyad is "CYAD."

What Is the Celyad Market Cap?

As of today, Celyad market cap is 10.30M EUR.

What Is Celyad's Earnings Per Share (TTM)?

The Celyad EPS (TTM) is 0.02.

When Is the Next Celyad Earnings Date?

Celyad will release its next earnings report on Sep 23, 2026.

From a Technical Analysis Perspective, Is CYAD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Celyad Stock Split?

Celyad has split 0 times.

How Many Employees Does Celyad Have?

Celyad has 5 employees.

What is the current trading status of Celyad (CYAD)?

As of Jun 26, 2026, Celyad (CYAD) is trading at a price of 0.23 EUR, with a previous close of 0.25 EUR. The stock has fluctuated within a day range of 0.23 EUR to 0.23 EUR, while its 52-week range spans from 0.16 EUR to 0.65 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.